LAS VEGAS — Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) (“Realbotix” or the “Company”), a leader in humanoid robotics and embodied AI, announces that its wholly owned subsidiary, Realbotix LLC, has agreed to an additional advance of US$500,000 in connection with the loan agreement entered into with Onconetix, Inc. (“Onconetix”) on September 14, 2026 in connection with the proposed merger transaction involving Realbotix LLC and Onconetix previously announced on February 12, 2026. Read More
Source link
Cizzle Brands Announces Filing of LIFE Offering Document
This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. “Forward-looking information” includes, but is not limited to, statements with respect to the activities, events or…





